Abstract
In this issue, Shah and colleagues reviewed and discussed the pharmacogenetics of tacrolimus in solid organ transplant patients, Ullah and colleagues performed a meta-analysis on the association of GABRG2 rs211037 gene polymorphism with epilepsies and pharmacoresistance to anti-epileptic drugs, Mansoor and colleagues carried out an integrative investigation for the prioritization of candidate genes and unveiled their interaction with celecoxib for targeted therapeutic applications, Nimra and Robab reviewed the pharmacogenomics of Leukemia for unlocking personalized treatment strategies, Hussain and colleagues investigated the association of GATM gene polymorphism with statin-induced myopathy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
